Sen­ate com­mit­tee ad­vances bi­par­ti­san PBM, FDA re­forms with eight re­lat­ed amend­ments

3 years ago
FDA+
Law

BioCryst de­buts print mag­a­zine for hered­i­tary an­gioede­ma pa­tients tak­ing Or­ladeyo

3 years ago
Pharma
Marketing

Man­u­fac­tur­ing roundup: Qual­i­ty is­sues at Sun Phar­ma plant in In­dia; Forge se­cures gene ther­a­py man­u­fac­tur­ing con­tract

3 years ago
Manufacturing

AAV pro­duc­er New­Bi­ologix emerges from stealth with $50M Se­ries A

3 years ago
Pharma
Cell/Gene Tx

In­novent show­cas­es topline PhII win for high-dose obe­si­ty drug in Chi­na

3 years ago
R&D
China

Italy's An­geli­ni Phar­ma teams up with JCR on blood-brain bar­ri­er deal

3 years ago
Deals
R&D

Ole­ma gives small up­date to breast can­cer drug at cen­ter of lay­offs, 2021 da­ta leak

3 years ago
R&D

Deer­field launch­es ra­dio­ther­a­py com­pa­ny; UCLA gene edit­ing spin­out se­cures funds

3 years ago
News Briefing

Sen­ate Fi­nance chair slams phar­ma in­dus­try's use of for­eign sub­sidiaries to cut their tax bills

3 years ago
Pharma
Law

New blood and cell ther­a­py-fo­cused ven­ture fund emerges with $50M and a Jen­nifer Doud­na spin­out in tow

3 years ago
Financing
Startups

BioN­Tech and Mati­nas end oral mR­NA de­liv­ery col­lab­o­ra­tion

3 years ago
Deals
R&D

Take­da winds down Ther­a­vance pact, culls part­nered Crohn's pro­gram af­ter PhII flops

3 years ago
R&D

FDA re­jects blad­der can­cer ther­a­py de­vel­oped by Patrick Soon-Sh­iong’s Im­mu­ni­ty­Bio

3 years ago
R&D
FDA+

Ex­clu­sive: Af­ter win­ning le­gal bat­tle, for­mer Phase­Bio in­vestor finds US buy­er for its PhI­II drug to re­verse Bril­in­ta

3 years ago
Deals

The E100: Ex­tend­ing run­ways, dump­ing drugs, fac­tor­ing in a bank­ing cri­sis and grap­pling with the IRA — there's a ...

3 years ago
Bioregnum
Special

Au­rinia’s board gets push­back from an­oth­er share­hold­er as Iljin fol­lows MKT Cap­i­tal’s lead

3 years ago
People

What's 'mean­ing­ful' phar­ma in­no­va­tion? House sub­com­mit­tee talks in­cen­tives

3 years ago
Pharma

Teva's new CEO Richard Fran­cis is plan­ning a 'new chap­ter' for the gener­ics gi­ant

3 years ago
Pharma

In­sulin prices in the Sen­ate hot seat: PBM and phar­ma fin­ger-point­ing con­tin­ues as land­scape shifts

3 years ago
Pharma

FDA ad­comm votes unan­i­mous­ly in fa­vor of ben­e­fit-risk pro­file of over-the-counter con­tra­cep­tive Opill

3 years ago
Pharma

‘Phar­ma Bro’ Mar­tin Shkre­li's com­pa­nies file for bank­rupt­cy

3 years ago
Pharma
Law

Stop the mu­sic: Pub­lic health ad­vo­cates join fight to ban ‘dis­trac­tion tech­nique’ in drug ads

3 years ago
Pharma
Marketing

AI and ma­chine learn­ing: FDA spells out specifics from drug dis­cov­ery to man­u­fac­tur­ing

3 years ago
Discovery
FDA+

Ic­ahn wins back­ing from share­hold­er ad­vi­so­ry firm in bid to re­move Il­lu­mi­na CEO from board

3 years ago
People
First page Previous page 345346347348349350351 Next page Last page
A service from the Financial Times